Cell‐penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival
2019 ◽
Vol 120
(10)
◽
pp. 18077-18087
◽
1992 ◽
Vol 7
(2)
◽
pp. 161-171
◽
1999 ◽
Vol 44
(3)
◽
pp. 193-202
◽
1991 ◽
Vol 9
(3)
◽
pp. 245-257
◽
2009 ◽
Vol 33
(9)
◽
pp. 995-1001
◽
2007 ◽
Vol 20
(5)
◽
pp. 569-578
◽